Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 24 May 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

New diagnosis of Barrett's esophagus changes insurance status

A diagnosis of Barrett's esophagus more than doubles life insurance premiums, and impacts the availability of health insurance, reports March's issue of The American Journal of Gastroenterology.

News image

fiogf49gjkf04

Barrett's esophagus is associated with an increased risk of adenocarcinoma of the esophagus.

Despite this increased risk, most cohort studies demonstrate that the mean life expectancy of subjects with Barrett's esophagus is no different than age-matched controls.

The indirect costs associated with a diagnosis of Barrett's esophagus are unclear.

Dr Shaheen and colleagues assessed the effect of a diagnosis of Barrett's esophagus on insurance premiums.

The researchers assessed 20 national life insurance companies (10 in southern California, 10 in North Carolina) to determine the effect of a diagnosis of Barrett's esophagus on life insurance premiums.

The investigators’ base case in Los Angeles was a 36 year old female nonsmoker, and in North Carolina, a 43 year old Caucasian male nonsmoker, both in excellent health except for a diagnosis of prevalent Barrett's esophagus with no dysplasia.

The investigative team then requested a policy of 20 year guaranteed term life insurance in the amount of $1,000,000.

Companies refused to provide health insurance to the individual with Barrett's esophagus or requested further medical review
The American Journal of Gastroenterology

Companies were asked for their best price exclusive of the Barrett's esophagus, and also their best price when considering Barrett's esophagus as a preexisting condition.

The researchers subsequently sent a physician's letter explaining Barrett's esophagus and providing data substantiating a normal life expectancy in the condition to those companies not offering the "preferred" rates.

The team also asked companies for health insurance quotes, including premiums and deductibles, inclusive and exclusive of the diagnosis of Barrett's esophagus.

The investigators contacted 29 national insurance companies and for the 43 year old man with no Barrett's esophagus, the yearly "preferred" premium for life insurance averaged $1,255.

The mean cost of the policies offered to the same individual with Barrett's esophagus as a preexisting condition was $2,731.

The researchers noted that for the 36 year old female the base rate exclusive of Barrett's esophagus was $517, with a range of $472 - $551.

After inclusion of the diagnosis of Barrett's esophagus, the mean rate rose by 177%, to $1,434, with a range of $1,144 - $1,896.

The investigators reported that companies either refused to provide health insurance to the individual with Barrett's esophagus or would not provide a quote without review of the medical record.

The team observed that none of the insurance companies changed their quoted rates after receiving the letter written by the physician on behalf of the individual.

Dr Shaheen concludes, “Despite the preponderance of data demonstrating a normal life expectancy associated with the condition, a diagnosis of Barrett's esophagus more than doubles life insurance premiums, and impacts the availability of health insurance.”

“Further steps to educate insurance companies about the risks associated with Barrett's esophagus are warranted, and patients should understand this additional "risk" of endoscopic screening for Barrett's esophagus.”

“There are significant indirect costs associated with a diagnosis of Barrett's esophagus.”

The American Journal of Gastroenterology 2005: 100(3): 577
09 March 2005

Go to top of page Email this page Email this page to a colleague

 24 May 2018 
Precision medicine for tumors
 24 May 2018 
Patient-reported outcome measures in IBD trials
 24 May 2018 
Alcohol consumption and outcomes in drug-induced liver injury
 23 May 2018 
High body mass index is and ulcerative colitis
 23 May 2018 
Management of perianal fistulas in Crohn’s disease
 23 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 22 May 2018 
Worldwide H.pylori prevalence
 22 May 2018 
PPI and risk of stroke
 22 May 2018 
Online tool predicts bowel dysfunction severity prior to anterior resection
 21 May 2018 
Fecal incontinence and quality of life in IBD
 21 May 2018 
PPI use and cognitive decline
 21 May 2018 
Depressive symptoms in IBD youth
 18 May 2018 
Esophageal dilatation in clinical practice 
 17 May 2018 
IBD and later extraintestinal manifestations
 17 May 2018 
Repeat stool DNA testing
 17 May 2018 
IBS and chronic fatigue following GI infection
 16 May 2018 
Factors associated with fecal incontinence
 16 May 2018 
Diagnostic delay in Crohn's disease
 16 May 2018 
Cardiovascular risk in diabetes mellitus with NAFLD
 15 May 2018 
Guidelines for management of Crohn's
 15 May 2018 
New therapies for CDI
 15 May 2018 
Hep B in the Grey Zone
 14 May 2018 
Blood test for the diagnosis of fibrotic NASH
 14 May 2018 
Outcomes at bariatric centers of excellence
 14 May 2018 
Management of perianal fistulas in Crohn’s
 11 May 2018 
Detection of undiagnosed celiac disease
 11 May 2018 
Alcohol consumption and drug-induced liver injury
 10 May 2018 
Colorectal cancer screening
 10 May 2018 
Post‐operative complications in elderly IBD
 10 May 2018 
Fibrosis in patients with chronic hepatitis B
 09 May 2018 
Esophageal dilatation in clinical practice 
 09 May 2018 
Fecal incontinence
 09 May 2018 
Health problems and IBS
 07 May 2018 
Omitting antibiotics in uncomplicated acute diverticulitis
 07 May 2018 
Health problems and IBS
 07 May 2018 
Assessment of diminutive colorectal polyps
 04 May 2018 
Factors associated with fecal incontinence
 04 May 2018 
National Institutes of Health workshop and obesity
 04 May 2018 
Colorectal cancer screening and ethnic inequities
 03 May 2018 
Gastrointestinal ultrasound in IBD
 03 May 2018 
Ultransonography in postsurgical recurrence in Crohn's
 02 May 2018 
Hep C antiviral treatment and liver cancer risk
 02 May 2018 
Symptom assessment in cirrhotic ascites
 02 May 2018 
Chronic Hep B
 01 May 2018 
European guidelines on pancreatic cystic neoplasms
 01 May 2018 
Interferon‐free regimens in Hep C
 01 May 2018 
Age at IBD onset and extraintestinal complications
 30 April 2018 
Formula for preterm infants
 30 April 2018 
Primary antibiotic resistance and sequential therapy for H. pylori
 27 April 2018 
Eastern and western practices for endoscopic resection of colorectal lesions
 27 April 2018 
Anxiety scale for chronic esophageal disease
 27 April 2018 
Disease activity in eosinophilic esophagitis
 26 April 2018 
Obesity and physical activity in diverticulosis
 26 April 2018 
Primary sclerosing cholangitis in the USA
 25 April 2018 
Aspirin and pancreatic cancer
 25 April 2018 
Central mediators of irinotecan-induced steatohepatitis
 25 April 2018 
Neuroimaging in Hep C
 24 April 2018 
Scoring system identifies cancer risk in Barrett's
 24 April 2018 
Microbiome in athletes vs sedentary subjects
 23 April 2018 
Genome-wide study on HBV-related acute-on-chronic liver failure

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us